Terms: = Colorectal cancer AND CDK12, KIAA0904, CRKRS, 51755, ENSG00000167258, CRK7, CRKR, Q9NYV4 AND Treatment
7 results:
1. cdk12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer.
Lu KQ; Li ZL; Zhang Q; Yin Q; Zhang YL; Ni WJ; Jiang LZ; He W; Wang B
Sci Rep; 2024 Mar; 14(1):6574. PubMed ID: 38503865
[TBL] [Abstract] [Full Text] [Related]
2. An Integrated Proteomics and Bioinformatics Analysis of the Anticancer Properties of RT2 Antimicrobial Peptide on Human Colon cancer (Caco-2) Cells.
Maijaroen S; Klaynongsruang S; Roytrakul S; Konkchaiyaphum M; Taemaitree L; Jangpromma N
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209215
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of cdk12 alterations in a pan-cancer database.
Pan E; Cabal A; Javier-DesLoges J; Patel D; Panian J; Lee S; Shaya J; Nonato T; Xu X; Stewart T; Rose B; Shabaik A; Cohen E; Kurzrock R; Tamayo P; McKay RR
Cancer Med; 2022 Feb; 11(3):753-763. PubMed ID: 34898046
[TBL] [Abstract] [Full Text] [Related]
4. Degradation of CCNK/cdk12 is a druggable vulnerability of colorectal cancer.
Dieter SM; Siegl C; Codó PL; Huerta M; Ostermann-Parucha AL; Schulz E; Zowada MK; Martin S; Laaber K; Nowrouzi A; Blatter M; Kreth S; Westermann F; Benner A; Uhrig U; Putzker K; Lewis J; Haegebarth A; Mumberg D; Holton SJ; Weiske J; Toepper LM; Scheib U; Siemeister G; Ball CR; Kuster B; Stoehr G; Hahne H; Johannes S; Lange M; Herbst F; Glimm H
Cell Rep; 2021 Jul; 36(3):109394. PubMed ID: 34289372
[TBL] [Abstract] [Full Text] [Related]
5. Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic colorectal cancer Receiving Oxaliplatin or Irinotecan-containing Regimens.
Marks EI; Matera R; Olszewski AJ; Yakirevich E; El-Deiry WS; Safran H; Carneiro BA
Am J Clin Oncol; 2021 Feb; 44(2):68-73. PubMed ID: 33298767
[TBL] [Abstract] [Full Text] [Related]
6. The promise and current status of cdk12/13 inhibition for the treatment of cancer.
Tadesse S; Duckett DR; Monastyrskyi A
Future Med Chem; 2021 Jan; 13(2):117-141. PubMed ID: 33295810
[TBL] [Abstract] [Full Text] [Related]
7. cdk12: an emerging therapeutic target for cancer.
Lui GYL; Grandori C; Kemp CJ
J Clin Pathol; 2018 Nov; 71(11):957-962. PubMed ID: 30104286
[TBL] [Abstract] [Full Text] [Related]
